0.0010
0.0000
(0.00%)
At close: January 31 at 3:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -0.26 | -1.2 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.35 | -0.33 | -0.31 | -0.27 |
| EPS Actual | -0.33 | -0.26 | -0.34 | -0.16 |
| Difference | 0.02 | 0.07 | -0.03 | 0.11 |
| Surprise % | 5.04% | 20.87% | -8.97% | 41.46% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GRTSQ | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Downgrade | Jones Trading: Buy to Hold | 10/2/2024 |
| Downgrade | B. Riley Securities: Buy to Neutral | 10/2/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 10/1/2024 |
| Downgrade | JMP Securities: Market Outperform to Market Perform | 10/1/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 8/5/2024 |
Related Tickers
MEIP MEI Pharma, Inc.
2.8500
0.00%
SNSE Sensei Biotherapeutics, Inc.
0.4700
-0.53%
NFX.L Nuformix plc
0.0700
-6.67%
NBY NovaBay Pharmaceuticals, Inc.
0.6655
+2.38%
IFRX InflaRx N.V.
2.4100
+1.69%
NEXI NexImmune, Inc.
0.1000
0.00%
LSTA Lisata Therapeutics, Inc.
2.5005
-3.46%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
RENB Renovaro Inc.
0.7500
-1.99%
NAMS NewAmsterdam Pharma Company N.V.
22.29
+2.39%